PUMA BIOTECHNOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 744.26 thousand shares for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2021-11-04
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-09-30 was 554.82K shares, a 634.76% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-06-30 was 155.71K shares, a 17.81% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-03-31 was 33.73K shares, a 88.23% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2020-12-31 was 164.04K shares, a 12.05% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2020 was 715.63K shares, a 9.46% decline from fiscal 2019.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2019 was 790.43K shares, a 121.44% increase from fiscal 2018.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2018 was 356.95K shares, a 194.17% increase from fiscal 2017.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2017 was 121.34K shares, a 8.03% decline from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2021-09-30 | 554.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 710.53K shares derived: sum of 2 quarters · filed 2021-11-04 | 744.26K shares 10-Q · filed 2021-11-04 | 908.29K shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | 155.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 189.44K shares 10-Q · filed 2021-08-05 | 353.48K shares derived: sum of 3 quarters · filed 2021-08-05 | 428.99K shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 33.73K shares 10-Q · filed 2021-05-06 | 197.77K shares derived: sum of 2 quarters · filed 2021-05-06 | 273.28K shares derived: sum of 3 quarters · filed 2021-05-06 | 462.73K shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | 164.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 239.55K shares derived: sum of 2 quarters · filed 2021-03-01 | 429.00K shares derived: sum of 3 quarters · filed 2021-03-01 | 715.63K shares 10-K · filed 2021-03-01 |
| 2020-09-30 | 75.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 264.96K shares derived: sum of 2 quarters · filed 2020-11-05 | 551.60K shares 10-Q · filed 2020-11-05 | 738.11K shares derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-06-30 | 189.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 476.09K shares 10-Q · filed 2020-08-06 | 662.60K shares derived: sum of 3 quarters · filed 2021-03-01 | 846.72K shares derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-03-31 | 286.64K shares 10-Q · filed 2020-05-07 | 473.15K shares derived: sum of 2 quarters · filed 2021-03-01 | 657.27K shares derived: sum of 3 quarters · filed 2021-03-01 | 888.75K shares derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-12-31 | 186.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 370.63K shares derived: sum of 2 quarters · filed 2021-03-01 | 602.11K shares derived: sum of 3 quarters · filed 2021-03-01 | 790.43K shares 10-K · filed 2021-03-01 |
| 2019-09-30 | 184.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 415.60K shares derived: sum of 2 quarters · filed 2019-11-07 | 603.92K shares 10-Q · filed 2019-11-07 | 714.83K shares derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | 231.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 419.79K shares 10-Q · filed 2019-08-09 | 530.71K shares derived: sum of 3 quarters · filed 2021-03-01 | 629.71K shares derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | 188.32K shares 10-Q · filed 2019-05-10 | 299.23K shares derived: sum of 2 quarters · filed 2021-03-01 | 398.23K shares derived: sum of 3 quarters · filed 2021-03-01 | 501.68K shares derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | 110.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 209.91K shares derived: sum of 2 quarters · filed 2021-03-01 | 313.36K shares derived: sum of 3 quarters · filed 2021-03-01 | 356.95K shares 10-K · filed 2021-03-01 |
| 2018-09-30 | 99.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | 202.45K shares derived: sum of 2 quarters · filed 2018-11-05 | 246.04K shares 10-Q · filed 2018-11-05 | 256.17K shares derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | 103.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 147.04K shares 10-Q · filed 2018-08-09 | 157.17K shares derived: sum of 3 quarters · filed 2020-02-28 | 186.75K shares derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | 43.60K shares 10-Q · filed 2018-05-10 | 53.72K shares derived: sum of 2 quarters · filed 2020-02-28 | 83.30K shares derived: sum of 3 quarters · filed 2020-02-28 | 136.87K shares derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | 10.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | 39.71K shares derived: sum of 2 quarters · filed 2020-02-28 | 93.28K shares derived: sum of 3 quarters · filed 2020-02-28 | 121.34K shares 10-K · filed 2020-02-28 |
| 2017-09-30 | 29.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 83.15K shares derived: sum of 2 quarters · filed 2017-11-09 | 111.22K shares 10-Q · filed 2017-11-09 | 171.35K shares derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | 53.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 81.64K shares 10-Q · filed 2017-08-09 | 141.77K shares derived: sum of 3 quarters · filed 2019-03-01 | 189.68K shares derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | 28.07K shares 10-Q · filed 2017-05-10 | 88.20K shares derived: sum of 2 quarters · filed 2019-03-01 | 136.11K shares derived: sum of 3 quarters · filed 2019-03-01 | 159.00K shares derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | 60.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | 108.05K shares derived: sum of 2 quarters · filed 2019-03-01 | 130.93K shares derived: sum of 3 quarters · filed 2019-03-01 | 131.93K shares 10-K · filed 2019-03-01 |
| 2016-09-30 | 47.91K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 70.80K shares derived: sum of 2 quarters · filed 2016-11-09 | 71.80K shares 10-Q · filed 2016-11-09 | 77.36K shares derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | 22.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 23.89K shares 10-Q · filed 2016-08-09 | 29.44K shares derived: sum of 3 quarters · filed 2018-03-09 | 29.69K shares derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | 1.00K shares 10-Q · filed 2016-05-10 | 6.55K shares derived: sum of 2 quarters · filed 2018-03-09 | 6.80K shares derived: sum of 3 quarters · filed 2018-03-09 | |
| 2015-12-31 | 5.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | 5.80K shares derived: sum of 2 quarters · filed 2018-03-09 | 7.85K shares 10-K · filed 2018-03-09 | |
| 2015-09-30 | 250.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 2.29K shares 10-Q · filed 2015-11-09 | ||
| 2015-06-30 | 2.04K shares 10-Q · filed 2015-08-10 | |||
| 2013-12-31 | 301.99K shares derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-12 | 314.62K shares 10-Q · filed 2014-05-12 | ||
| 2013-09-30 | 12.64K shares 10-Q · filed 2013-11-12 | |||
| 2012-12-31 | 11.67K shares 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |